Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2056-9920
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma ; volume:7 ; number:1 ; day:4 ; month:12 ; year:2021 ; pages:1-7 ; date:12.2021
International Journal of Retina and Vitreous ; 7, Heft 1 (4.12.2021), 1-7, 12.2021
- Creator
-
Anthony, Casey L.
Bavinger, J. Clay
Shantha, Jessica G.
O’Keefe, Ghazala D.
Pearce, William A.
Voloschin, Alfredo
Grossniklaus, Hans E.
Yeh, Steven
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40942-021-00346-0
- URN
-
urn:nbn:de:101:1-2022020720542247493356
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Anthony, Casey L.
- Bavinger, J. Clay
- Shantha, Jessica G.
- O’Keefe, Ghazala D.
- Pearce, William A.
- Voloschin, Alfredo
- Grossniklaus, Hans E.
- Yeh, Steven
- SpringerLink (Online service)
Other Objects (12)
Retinal changes of primary vitreoretinal lymphoma after intravitreal methotrexate
Longitudinal observation of OCT imaging is a valuable tool to monitor primary vitreoretinal lymphoma treated with intravitreal injections of methotrexate
Reduced frequency of Intravitreal methotrexate injection lowers the risk of Keratopathy in Vitreoretinal lymphoma patients
Electrophysiological Monitoring of Focal and Entire Retinal Function during Treatment with Intravitreal Methotrexate for Intraocular Lymphoma
Primary Vitreoretinal Lymphoma Therapy Monitoring: Significant Vitreous Haze Reduction After Intravitreal Rituximab
Methotrexate-Associated Lymphoproliferative Disorder with Intraocular Involvement Improved with Intravitreal Methotrexate and Chemotherapy: A Case Report
Reversible methotrexate-associated lymphoma of the liver in rheumatoid arthritis: a unique case of primary hepatic lymphoma
High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)
High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)
Subacute quadriplegic myelopathy following intrathecal methotrexate
Rhegmatogenous retinal detachment following intravitreal ocriplasmin
Differential expression of N-linked oligosaccharides in methotrexate-resistant primary central nervous system lymphoma cells
Retinal changes of primary vitreoretinal lymphoma after intravitreal methotrexate
Longitudinal observation of OCT imaging is a valuable tool to monitor primary vitreoretinal lymphoma treated with intravitreal injections of methotrexate
Reduced frequency of Intravitreal methotrexate injection lowers the risk of Keratopathy in Vitreoretinal lymphoma patients
Electrophysiological Monitoring of Focal and Entire Retinal Function during Treatment with Intravitreal Methotrexate for Intraocular Lymphoma
Primary Vitreoretinal Lymphoma Therapy Monitoring: Significant Vitreous Haze Reduction After Intravitreal Rituximab
Methotrexate-Associated Lymphoproliferative Disorder with Intraocular Involvement Improved with Intravitreal Methotrexate and Chemotherapy: A Case Report
Reversible methotrexate-associated lymphoma of the liver in rheumatoid arthritis: a unique case of primary hepatic lymphoma
High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)
High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)
Subacute quadriplegic myelopathy following intrathecal methotrexate
Rhegmatogenous retinal detachment following intravitreal ocriplasmin
Differential expression of N-linked oligosaccharides in methotrexate-resistant primary central nervous system lymphoma cells
Retinal changes of primary vitreoretinal lymphoma after intravitreal methotrexate
Longitudinal observation of OCT imaging is a valuable tool to monitor primary vitreoretinal lymphoma treated with intravitreal injections of methotrexate
Reduced frequency of Intravitreal methotrexate injection lowers the risk of Keratopathy in Vitreoretinal lymphoma patients
Electrophysiological Monitoring of Focal and Entire Retinal Function during Treatment with Intravitreal Methotrexate for Intraocular Lymphoma
Primary Vitreoretinal Lymphoma Therapy Monitoring: Significant Vitreous Haze Reduction After Intravitreal Rituximab
Methotrexate-Associated Lymphoproliferative Disorder with Intraocular Involvement Improved with Intravitreal Methotrexate and Chemotherapy: A Case Report
Reversible methotrexate-associated lymphoma of the liver in rheumatoid arthritis: a unique case of primary hepatic lymphoma
High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)
High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)
Subacute quadriplegic myelopathy following intrathecal methotrexate
Rhegmatogenous retinal detachment following intravitreal ocriplasmin